Bendamustine

5 trials 2 recruiting

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

2 Recruiting

3 Completed trials

5 Sponsors

14 Countries

Phase III

Phase II

Phase III: 2 Phase II: 3

Oversight events:

5 temporary halts across 1 trial

View oversight register →

Indications tested

Mantle cell lymphoma stage II 1 Mantle cell lymphoma stage IV 1 Mantle cell lymphoma stage III 1

Sponsors using this IMP

Acerta Pharma B.V. 1 Fondazione Italiana Linfomi Ets 1 Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer 1 Klinikum der Universitaet Muenchen AöR 1 Novartis Pharma AG 1

All trials

5 total

CAR-T-cell treatment for untreated high risk MANtle Cell Lymphoma Recruiting

2022-502405-15-01 Phase II 5 countries Klinikum Der Universitat Munchen AöR
Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy Recruiting

2024-513601-31-00 Phase II 1 country Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques Augus…
Shortened vs standard chemotherapy combined with immunotherapy for the initial treatment of patients with high tumor burden Follicular Lymph… Ended

2024-511636-27-00 Phase III 1 country Fondazione Italiana Linfomi Ets
This study is being done to test the effectiveness and safety of an investigational drug called acalabrutinib (ACP-196) when taken with alre… Ended

2023-509349-11-00 Phase III 13 countries Acerta Pharma B.V.
A Phase 2 study of durcabtagene autoleucel, B-cell maturation Antigen (BCMA)-directed CAR-T Cells in adult participants with relapsed and re… Ended

2023-507140-37-00 Phase II 5 countries Novartis Pharma AG

Showing 1–5 of 5 trials

← All drugs A–Z